Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Goodwill: 2018-2025

Historic Goodwill for Dr Reddys Laboratories (RDY) over the last 8 years, with Mar 2025 value amounting to $138.0 million.

  • Dr Reddys Laboratories' Goodwill rose 170.59% to $138.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $138.0 million, marking a year-over-year increase of 170.59%. This contributed to the annual value of $138.0 million for FY2025, which is 170.59% up from last year.
  • As of FY2025, Dr Reddys Laboratories' Goodwill stood at $138.0 million, which was up 170.59% from $51.0 million recorded in FY2024.
  • In the past 5 years, Dr Reddys Laboratories' Goodwill registered a high of $138.0 million during FY2025, and its lowest value of $51.0 million during FY2024.
  • Its 3-year average for Goodwill is $80.3 million, with a median of $52.0 million in 2023.
  • As far as peak fluctuations go, Dr Reddys Laboratories' Goodwill dropped by 10.34% in 2023, and later skyrocketed by 170.59% in 2025.
  • Dr Reddys Laboratories' Goodwill (Yearly) stood at $62.0 million in 2021, then fell by 6.45% to $58.0 million in 2022, then dropped by 10.34% to $52.0 million in 2023, then declined by 1.92% to $51.0 million in 2024, then soared by 170.59% to $138.0 million in 2025.